RET is an oncogene that can be overactivated either i) by a fusion rearrangement of the TK domain of RET gene and the 5′ domain of other genes (known as RET/PTC rearrangements) or ii) by activating point mutations; RET alterations lead to activation of mitogen-activated MAPK pathway, resulting in cancer development. Here, RET is linked to cancer.